Strategy Note /

Omicron Covid in emerging markets

Covid precedent: sell-off temporary, tech outperforms at first, commodities recover before manufacturing, tourism lags
Differences today (Omicron) vs Delta in Q1 2021: 1) higher vaccination and prior infection, 2) less space for stimulus
We chart vaccination, prior infection, lockdowns, real interest rates, fiscal deficits across EM and key DM comparables

Hasnain Malik

Strategy & Head of Equity Research @ Tellimer Research

28 November 2021

Published by

Tellimer Research

Share this article

Most ViewedSee latest

Disclosures:

This report is independent investment research as contemplated by COBS 12.2 of the FCA Handbook and is a research recommendation under COBS 12.4 of the FCA Handbook. Where it is not technically a research recommendation because the subject of the research is not listed on any European exchange, it has nevertheless been treated as a research recommendation to ensure consistent treatment of all Tellimer's research. This report has been produced by the analyst(s) named above (the "Analyst").

The Analyst certifies that the views and forecasts expressed in this report accurately reflect their personal views about the subject, securities, or issuers specified herein. In addition, the Analyst certifies that no part of their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this report.

Research ratings explanation and full Tellimer disclaimers

Full Tellimer disclaimers